Profile | GDS2987 / GI_31543409-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 7.7 | 27 |
GSM215244 | HMVEC_vehicle_rep2 | ||
GSM215253 | HMVEC_vehicle_rep3 | 6.1 | 21 |
GSM215254 | HMVEC_atorvastatin_rep1 | 9.7 | 26 |
GSM215282 | HMVEC_atorvastatin_rep3 | 0.2 | 0 |
GSM215344 | HMVEC_atorvastatin_rep2 | 16 | 38 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 37.7 | 57 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 13.5 | 27 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 32.5 | 47 |
GSM215294 | HMVEC_SLx2119_rep1 | 12.3 | 41 |
GSM215295 | HMVEC_SLx2119_rep2 | 7.6 | 16 |
GSM215296 | HMVEC_SLx2119_rep3 | 10.3 | 17 |
GSM215297 | PASMC_vehicle_rep1 | 22.7 | 34 |
GSM215298 | PASMC_vehicle_rep2 | 18.5 | 28 |
GSM215310 | PASMC_vehicle_rep3 | 16 | 26 |
GSM215311 | PASMC_atorvastatin_rep1 | 30.3 | 47 |
GSM215312 | PASMC_atorvastatin_rep2 | 4.6 | 8 |
GSM215313 | PASMC_atorvastatin_rep3 | 17.1 | 25 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | ||
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 4 | 8 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 41.7 | 57 |
GSM215327 | PASMC_SLx2119_rep1 | 7.9 | 14 |
GSM215328 | PASMC_SLx2119_rep2 | 27.8 | 45 |
GSM215329 | PASMC_SLx2119_rep3 | 37.1 | 56 |
GSM215330 | Fibroblasts_vehicle_rep1 | 15.6 | 35 |
GSM215331 | Fibroblasts_vehicle_rep2 | 7.2 | 21 |
GSM215332 | Fibroblasts_vehicle_rep3 | 22.8 | 56 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 22.6 | 51 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 19.2 | 47 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | ||
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 19.2 | 52 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 1 | 3 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 20.1 | 48 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 30.2 | 61 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 13.1 | 35 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 10.4 | 26 |